TRDA20250620C20
TRDA Jun 20 2025 20.00 Call (TRDA250620C00020000)
option OPRA

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.